[Translated article] Toxicity of the FOLFOX-6 regimen, with or without 5-fluorouracil bolus, in metastatic colorectal cancer
The TTD regimen could be a beneficial first-line option for metastatic colorectal cancer, with lower toxicity and effectiveness comparable to FOLFOX-6. It is a safe alternative for elderly or frail patients, suitable for reduced-dose 5-fluorouracil regimen with oxaliplatin.
Authors
- Victoria Aviñó Tarazona
- María Isabel Guzmán Ramos
- María Teresa Garrido Martínez
- Mónica Jorge
- I García Giménez
- Salvador Grutzmancher Sáiz
Institutions
- Hospital Juan Ramón Jiménez (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.farma.2024.12.006
- Citations
- 2
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.09